News Sentiment

BIOV sentiment intelligence

BioVersys AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange EBS Switzerland
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.50 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+1.9% over one week, +5.0% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

BioVersys publishes BV100 phase 1 data, advances phase 3 trial

Market Reaction

Balanced read

57/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 1.9% Price digesting
Trend fit Trend active 5.0% over four weeks
Fair value -6.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing.com 1
simplywall.st 1
Venturelab Swiss 1
marketscreener.com 1
Startupticker.ch 1

Event Lens

What the news is about

Classified themes
Market update 4
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5